Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$26,184,758
+$10,535,792 QoQ
Shares Held
21,831
+28.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.36%
of 13F equity value
Holder Rank
#779
of 4,632 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$15,613
PutShares
500
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Larson Financial Group LLC holds $64,664,035 across 17 Drug Manufacturers - General names. LLY ranks #1 (40.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
21,831 | $26,184,758 | |
| 2 | ABBV |
AbbVie Inc.
|
35,918 | $9,038,405 | |
| 3 | MRK |
Merck & Co., Inc.
|
63,932 | $8,215,262 | |
| 4 | PFE |
Pfizer Inc
|
310,250 | $7,470,820 | |
| 5 | JNJ |
Johnson & Johnson
|
27,845 | $7,071,794 | |
| 6 | AMGN |
Amgen Inc
|
7,025 | $2,543,893 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
25,994 | $1,497,774 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
11,716 | $1,480,199 |
All Filings in LLY
Export CSV
28 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,184,758 | 21,831 | Shares | Sole | 2026-08-14 | |
| 2026-06-30 | $15,613 | 500 | Put | Sole | 2026-08-14 | |
| 2026-03-31 | $67,719 | 500 | Put | Sole | 2026-05-15 | |
| 2026-03-31 | $15,648,966 | 17,014 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $15,051,969 | 14,006 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $12,788,643 | 16,761 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $12,876,276 | 16,518 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $13,365,701 | 16,183 | Shares | Sole | 2025-05-02 | |
| 2024-12-31 | $11,854,060 | 15,355 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $13,150,893 | 14,844 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $13,711,074 | 15,144 | Shares | Sole | 2024-08-02 | |
| 2024-03-31 | $7,299,598 | 9,383 | Shares | Sole | 2024-05-03 | |
| 2023-12-31 | $5,370,441 | 9,213 | Shares | Sole | 2024-02-01 | |
| 2023-09-30 | $4,805,702 | 8,947 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,838,401 | 3,920 | Shares | Sole | 2023-08-03 | |
| 2023-03-31 | $1,401,840 | 4,082 | Shares | Sole | 2023-05-04 | |
| 2022-12-31 | $1,457,140 | 3,983 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,287,256 | 3,981 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $1,230,452 | 3,795 | Shares | Sole | 2022-08-04 | |
| 2022-03-31 | $872,855 | 3,048 | Shares | Sole | 2022-05-05 | |
| 2021-12-31 | $822,859 | 2,979 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $322,776 | 1,397 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $366,084 | 1,595 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $297,604 | 1,593 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $176,775 | 1,047 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $154,828 | 1,046 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $171,732 | 1,046 | Shares | Sole | 2020-07-10 | |
| 2020-03-31 | $145,101 | 1,046 | Shares | Sole | 2020-04-09 | |
| No filing history on record for this holder in this stock. | ||||||